Navellier & Associates’s MiMedx Group MDXG Stock Holding History

Navellier & Associates’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-18,802	Closed	-$120K	–	323
2018 Q2	$120K	Buy	18,802 +4,333	+30%	+$30.8K	0.02%	280
2018 Q1	$101K	Sell	14,469 -376	-3%	-$4.38K	0.02%	277
2017 Q4	$187K	Sell	14,845 -277	-2%	-$3.38K	0.04%	259
2017 Q3	$180K	Buy	+15,122	New	+$224K	0.04%	211
2016 Q4	–	Sell	-17,900	Closed	-$154K	–	308
2016 Q3	$154K	Hold	17,900	–	–	0.02%	243
2016 Q2	$143K	Hold	17,900	–	–	0.02%	232
2016 Q1	$156K	Hold	17,900	–	–	0.02%	201
2015 Q4	$168K	Hold	17,900	–	–	0.02%	209
2015 Q3	$173K	Hold	17,900	–	–	0.02%	253
2015 Q2	$207K	Buy	+17,900	New	+$184K	0.02%	338

Other funds holding MDXG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Tiedemann Advisors New York $2.33B AUM 15.56% 1-Year Est. Return

Navellier & Associates's MDXG Position: Q3 2018 in Review

Navellier & Associates sold out of MiMedx Group (MDXG) in Q3 2018, closing a stake of 18,802 shares — an estimated $120K sold.

Navellier & Associates first reported a position in MDXG in Q2 2015 and held it in 10 quarters. The position peaked at $207K in Q2 2015. 186 funds tracked by Wall St. Rank hold MDXG as of Q3 2018.

Navellier & Associates reported no remaining MiMedx Group position as of Q3 2018 after selling out during the quarter.
Navellier & Associates sold 18,802 MiMedx Group shares in Q3 2018, an estimated $120K.
Navellier & Associates first reported a position in MiMedx Group in Q2 2015 and held it in 10 quarters.
Navellier & Associates's MiMedx Group position peaked at $207K in Q2 2015.
186 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2018.

Based on Navellier & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.